Stavroula Droufakou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Stavroula Droufakou has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alexios Matikas
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
1 shared publication - Anastassios Philippou
Department of Physiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
1 shared publication - Antonios Giannopoulos
Section of Sports Medicine, Department of Community Medicine & Rehabilitation, Umeå University, 901 87 Umeå, Sweden
1 shared publication - Argyro Papadopetraki
Department of Physiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece
1 shared publication - Davide Mauri
Department of Medical Oncology, University of Ioannina, Ioannina 45110, Greece
1 shared publication - Doris Sau Man Chan
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK
1 shared publication
Latest Publications
- Open Access
- 25 December 2024
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 207, 104602
Grading the evidence for physical activity and any outcome in cancer survivors: An Umbrella review of 740 meta-analytic associations
- 25 December 2024
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 207, 104602
Open AccessGrading the evidence for physical activity and any outcome in cancer survivors: An Umbrella review of 740 meta-analytic associations
- Open Access
The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity
One of the most common adverse effects of cancer and its therapeutic strategies is sarcopenia, a condition which is characterised by excess muscle wasting and muscle strength loss due to the disrupted muscle homeostasis. Moreover, cancer-related sarcopenia may be combined with the increased deposition of fat mass, a syndrome called cancer-associated sarcopenic obesity. Both clinical conditions have significant clinical importance and can predict disease progression and survival. A growing body of evidence supports the claim that physical exercise is a safe and effective complementary therapy for oncology patients which can limit the cancer- and its treatment-related muscle catabolism and promote the maintenance of muscle mass. Moreover, even after the onset of sarcopenia, exercise interventions can counterbalance the muscle mass loss and improve the clinical appearance and quality of life of cancer patients. The aim of this narrative review was to describe the various pathophysiological mechanisms, such as protein synthesis, mitochondrial function, inflammatory response, and the hypothalamic–pituitary–adrenal axis, which are regulated by exercise and contribute to the management of sarcopenia and sarcopenic obesity. Moreover, myokines, factors produced by and released from exercising muscles, are being discussed as they appear to play an important role in mediating the beneficial effects of exercise against sarcopenia.
Open AccessThe Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity
One of the most common adverse effects of cancer and its therapeutic strategies is sarcopenia, a condition which is characterised by excess muscle wasting and muscle strength loss due to the disrupted muscle homeostasis. Moreover, cancer-related sarcopenia may be combined with the increased deposition of fat mass, a syndrome called cancer-associated sarcopenic obesity. Both clinical conditions have significant clinical importance and can predict disease progression and survival. A growing body of evidence supports the claim that physical exercise is a safe and effective complementary therapy for oncology patients which can limit the cancer- and its treatment-related muscle catabolism and promote the maintenance of muscle mass. Moreover, even after the onset of sarcopenia, exercise interventions can counterbalance the muscle mass loss and improve the clinical appearance and quality of life of cancer patients. The aim of this narrative review was to describe the various pathophysiological mechanisms, such as protein synthesis, mitochondrial function, inflammatory response, and the hypothalamic–pituitary–adrenal axis, which are regulated by exercise and contribute to the management of sarcopenia and sarcopenic obesity. Moreover, myokines, factors produced by and released from exercising muscles, are being discussed as they appear to play an important role in mediating the beneficial effects of exercise against sarcopenia.
- Open Access
- 27 May 2022
- Published by European Publishing in Public Health and Toxicology
- Vol. 2 (Supplement)
How does lifestyle impact incidence of cancer: Preventive measures to consider
- 27 May 2022
- Published by European Publishing in Public Health and Toxicology
- Vol. 2 (Supplement)
Open AccessHow does lifestyle impact incidence of cancer: Preventive measures to consider